兔抗CLPTM1L多克隆抗體

Background:

Cleft lip and palate transmembrane protein 1-like protein (CLPTM1-like protein), also known as cisplatin resistance-related protein 9 (CRR9p), is a protein that in humans is encoded by the CLPTM1L gene. CRR9p is associated with cisplatin-induced apoptosis. CLPTM1L, which lies within a cancer susceptibility locus on chromosome 5 (5p15.33), has been found to be commonly over-expressed in lung tumors and to confer resistance to apoptosis caused by genotoxic agents in association with up-regulation of the anti-apoptotic protein, Bcl-xL.

Applications:

ELISA, IHC

Name of antibody:

CLPTM1L

Immunogen:

Synthetic peptide of human CLPTM1L

Full name:

CLPTM1-like

Synonyms：

CRR9

SwissProt:

Q96KA5

ELISA Recommended dilution:

1000-5000

IHC positive control:

Human thyroid cancer and Human esophagus cancer

IHC Recommend dilution:

50-200